IFNAR1 and melanoma: Our exploratory analyses using the TIMER database revealed a strong positive correlation between IFN-α/β receptor (IFNAR) and YTHDF1 in 4 cancer types including melanoma, glioma, prostate, and liver cancer (P < 0.001, Supplemental Figure 6, F and G).